🇺🇸 FDA
Patent

US 6117640

Recombinant vaccine made in E. coli against dengue virus

expired A61KA61K39/00A61P

Quick answer

US patent 6117640 (Recombinant vaccine made in E. coli against dengue virus) held by The United States of America as represented by the Secretary of the Army expires Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Sep 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K39/00, A61P, A61P31/12